Global and Japan Polypeptide Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Sep-2020
No. of pages: 149
Inquire Before Buying

Polypeptide Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Polypeptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Polypeptide Drug market is segmented into

- Injection

- Nasal Administration

- Lung Administration

- Oral Administration

- Transdermal Administration

Segment by Application, the Polypeptide Drug market is segmented into

- Immunity Regulating Medicine (Allergy Infection and Immune)

- Digestive System Drugs (Gastrointestinal Type)

- Bone and Connective Tissue Types (Thyroid hormones Drug)

- Gynecologic or Obstetric Drug

- Tumor Drug

- Urinary System Drug

- Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Regional and Country-level Analysis

The Polypeptide Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Polypeptide Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Polypeptide Drug Market Share Analysis

Polypeptide Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polypeptide Drug business, the date to enter into the Polypeptide Drug market, Polypeptide Drug product introduction, recent developments, etc.

The major vendors covered:

- Novartis

- Merck Serono

- Ferring Pharmaceuticals

- Ipsen PHarma Biotech

- Lilly

- Asahi Kasei

- AstraZeneca

- SciClone Pharmaceuticals

- Takeda

- Roche

- Sanofi

Global and Japan Polypeptide Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Polypeptide Drug Product Introduction
1.2 Market Segments
1.3 Key Polypeptide Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Polypeptide Drug Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Nasal Administration
1.4.4 Lung Administration
1.4.5 Oral Administration
1.4.6 Transdermal Administration
1.5 Market by Application
1.5.1 Global Polypeptide Drug Market Size Growth Rate by Application
1.5.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.5.3 Digestive System Drugs (Gastrointestinal Type)
1.5.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.5.5 Gynecologic or Obstetric Drug
1.5.6 Tumor Drug
1.5.7 Urinary System Drug
1.5.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Polypeptide Drug Market Size, Estimates and Forecasts
2.1.1 Global Polypeptide Drug Revenue 2015-2026
2.1.2 Global Polypeptide Drug Sales 2015-2026
2.2 Global Polypeptide Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Polypeptide Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Polypeptide Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Polypeptide Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Polypeptide Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Polypeptide Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Polypeptide Drug Revenue Forecast by Region (2021-2026)
3 Global Polypeptide Drug Competitor Landscape by Players
3.1 Global Top Polypeptide Drug Sales by Manufacturers
3.1.1 Global Polypeptide Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Polypeptide Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Polypeptide Drug Manufacturers by Revenue
3.2.1 Global Polypeptide Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Polypeptide Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Polypeptide Drug Revenue in 2019
3.2.5 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Polypeptide Drug Price by Manufacturers
3.4 Global Polypeptide Drug Manufacturing Base Distribution, Product Types
3.4.1 Polypeptide Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polypeptide Drug Product Type
3.4.3 Date of International Manufacturers Enter into Polypeptide Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Polypeptide Drug Market Size by Type (2015-2020)
4.1.1 Global Polypeptide Drug Sales by Type (2015-2020)
4.1.2 Global Polypeptide Drug Revenue by Type (2015-2020)
4.1.3 Polypeptide Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Polypeptide Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Polypeptide Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Polypeptide Drug Revenue Forecast by Type (2021-2026)
4.2.3 Polypeptide Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Polypeptide Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Polypeptide Drug Market Size by Application (2015-2020)
5.1.1 Global Polypeptide Drug Sales by Application (2015-2020)
5.1.2 Global Polypeptide Drug Revenue by Application (2015-2020)
5.1.3 Polypeptide Drug Price by Application (2015-2020)
5.2 Polypeptide Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Polypeptide Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Polypeptide Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Polypeptide Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Polypeptide Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Polypeptide Drug Sales YoY Growth 2015-2026
6.1.2 Japan Polypeptide Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Polypeptide Drug Market Share in Global Market 2015-2026
6.2 Japan Polypeptide Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Polypeptide Drug Players by Sales (2015-2020)
6.2.2 Japan Top Polypeptide Drug Players by Revenue (2015-2020)
6.3 Japan Polypeptide Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Polypeptide Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Polypeptide Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Polypeptide Drug Price by Type (2015-2020)
6.4 Japan Polypeptide Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Polypeptide Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Polypeptide Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Polypeptide Drug Price Forecast by Type (2021-2026)
6.5 Japan Polypeptide Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Polypeptide Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Polypeptide Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Polypeptide Drug Price by Application (2015-2020)
6.6 Japan Polypeptide Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Polypeptide Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Polypeptide Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Polypeptide Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Polypeptide Drug Market Size YoY Growth 2015-2026
7.2 North America Polypeptide Drug Market Facts & Figures by Country
7.2.1 North America Polypeptide Drug Sales by Country (2015-2020)
7.2.2 North America Polypeptide Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Polypeptide Drug Market Size YoY Growth 2015-2026
8.2 Europe Polypeptide Drug Market Facts & Figures by Country
8.2.1 Europe Polypeptide Drug Sales by Country
8.2.2 Europe Polypeptide Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Polypeptide Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Polypeptide Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Polypeptide Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Polypeptide Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Polypeptide Drug Market Size YoY Growth 2015-2026
10.2 Latin America Polypeptide Drug Market Facts & Figures by Country
10.2.1 Latin America Polypeptide Drug Sales by Country
10.2.2 Latin America Polypeptide Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Polypeptide Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Polypeptide Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Polypeptide Drug Sales by Country
11.2.2 Middle East and Africa Polypeptide Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Polypeptide Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Merck Serono
12.2.1 Merck Serono Corporation Information
12.2.2 Merck Serono Description and Business Overview
12.2.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Serono Polypeptide Drug Products Offered
12.2.5 Merck Serono Recent Development
12.3 Ferring Pharmaceuticals
12.3.1 Ferring Pharmaceuticals Corporation Information
12.3.2 Ferring Pharmaceuticals Description and Business Overview
12.3.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ferring Pharmaceuticals Polypeptide Drug Products Offered
12.3.5 Ferring Pharmaceuticals Recent Development
12.4 Ipsen PHarma Biotech
12.4.1 Ipsen PHarma Biotech Corporation Information
12.4.2 Ipsen PHarma Biotech Description and Business Overview
12.4.3 Ipsen PHarma Biotech Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ipsen PHarma Biotech Polypeptide Drug Products Offered
12.4.5 Ipsen PHarma Biotech Recent Development
12.5 Lilly
12.5.1 Lilly Corporation Information
12.5.2 Lilly Description and Business Overview
12.5.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lilly Polypeptide Drug Products Offered
12.5.5 Lilly Recent Development
12.6 Asahi Kasei
12.6.1 Asahi Kasei Corporation Information
12.6.2 Asahi Kasei Description and Business Overview
12.6.3 Asahi Kasei Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Asahi Kasei Polypeptide Drug Products Offered
12.6.5 Asahi Kasei Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Corporation Information
12.7.2 AstraZeneca Description and Business Overview
12.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AstraZeneca Polypeptide Drug Products Offered
12.7.5 AstraZeneca Recent Development
12.8 SciClone Pharmaceuticals
12.8.1 SciClone Pharmaceuticals Corporation Information
12.8.2 SciClone Pharmaceuticals Description and Business Overview
12.8.3 SciClone Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SciClone Pharmaceuticals Polypeptide Drug Products Offered
12.8.5 SciClone Pharmaceuticals Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Description and Business Overview
12.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Polypeptide Drug Products Offered
12.9.5 Takeda Recent Development
12.10 Roche
12.10.1 Roche Corporation Information
12.10.2 Roche Description and Business Overview
12.10.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Roche Polypeptide Drug Products Offered
12.10.5 Roche Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Polypeptide Drug Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Polypeptide Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polypeptide Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Polypeptide Drug Market Segments
Table 2. Ranking of Global Top Polypeptide Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Polypeptide Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Nasal Administration
Table 6. Major Manufacturers of Lung Administration
Table 7. Major Manufacturers of Oral Administration
Table 8. Major Manufacturers of Transdermal Administration
Table 9. Global Polypeptide Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 10. Global Polypeptide Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 11. Global Polypeptide Drug Sales by Regions 2015-2020 (MT)
Table 12. Global Polypeptide Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Polypeptide Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Polypeptide Drug Sales Forecast by Region (2021-2026) (MT)
Table 15. Global Polypeptide Drug Sales by Manufacturers (2015-2020) (MT)
Table 16. Global Polypeptide Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Polypeptide Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Polypeptide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypeptide Drug as of 2019)
Table 19. Polypeptide Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Polypeptide Drug Price (2015-2020) (USD/MT)
Table 22. Polypeptide Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Polypeptide Drug Product Type
Table 24. Date of International Manufacturers Enter into Polypeptide Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 27. Global Polypeptide Drug Sales Share by Type (2015-2020)
Table 28. Global Polypeptide Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Polypeptide Drug Revenue Share by Type (2015-2020)
Table 30. Polypeptide Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Polypeptide Drug Sales Share by Type (2021-2026)
Table 32. Global Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 33. Global Polypeptide Drug Sales Share by Application (2015-2020)
Table 34. Global Polypeptide Drug Sales Share by Application (2021-2026)
Table 35. Global Polypeptide Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Polypeptide Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Polypeptide Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Polypeptide Drug Sales (MT) of Key Companies (2015-2020)
Table 39. Japan Polypeptide Drug Sales Share by Company (2015-2020)
Table 40. Japan Polypeptide Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Polypeptide Drug Sales (MT) by Type (2015-2020)
Table 42. Japan Polypeptide Drug Sales Share by Type (2015-2020)
Table 43. Japan Polypeptide Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Polypeptide Drug Price (MT) by Type (2015-2020)
Table 45. Japan Polypeptide Drug Sales (MT) by Type (2021-2026)
Table 46. Japan Polypeptide Drug Sales Share by Type (2021-2026)
Table 47. Japan Polypeptide Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Polypeptide Drug Revenue Share by Type (2021-2026)
Table 49. Japan Polypeptide Drug Price (MT) by Type (2021-2026)
Table 50. Japan Polypeptide Drug Sales (MT) by Application (2015-2020)
Table 51. Japan Polypeptide Drug Sales Share by Application (2015-2020)
Table 52. Japan Polypeptide Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Polypeptide Drug Sales (MT) by Application (2021-2026)
Table 54. Japan Polypeptide Drug Sales Share by Application (2021-2026)
Table 55. Japan Polypeptide Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Polypeptide Drug Revenue Share by Application (2021-2026)
Table 57. North America Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 58. North America Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 59. North America Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 62. Europe Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Polypeptide Drug Sales by Region (2015-2020) (MT)
Table 66. Asia Pacific Polypeptide Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Polypeptide Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Polypeptide Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 70. Latin America Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 74. Middle East and Africa Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Novartis Polypeptide Drug Product
Table 81. Novartis Recent Development
Table 82. Merck Serono Corporation Information
Table 83. Merck Serono Description and Business Overview
Table 84. Merck Serono Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Merck Serono Product
Table 86. Merck Serono Recent Development
Table 87. Ferring Pharmaceuticals Corporation Information
Table 88. Ferring Pharmaceuticals Description and Business Overview
Table 89. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Ferring Pharmaceuticals Product
Table 91. Ferring Pharmaceuticals Recent Development
Table 92. Ipsen PHarma Biotech Corporation Information
Table 93. Ipsen PHarma Biotech Description and Business Overview
Table 94. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Ipsen PHarma Biotech Product
Table 96. Ipsen PHarma Biotech Recent Development
Table 97. Lilly Corporation Information
Table 98. Lilly Description and Business Overview
Table 99. Lilly Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Lilly Product
Table 101. Lilly Recent Development
Table 102. Asahi Kasei Corporation Information
Table 103. Asahi Kasei Description and Business Overview
Table 104. Asahi Kasei Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Asahi Kasei Product
Table 106. Asahi Kasei Recent Development
Table 107. AstraZeneca Corporation Information
Table 108. AstraZeneca Description and Business Overview
Table 109. AstraZeneca Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. AstraZeneca Product
Table 111. AstraZeneca Recent Development
Table 112. SciClone Pharmaceuticals Corporation Information
Table 113. SciClone Pharmaceuticals Description and Business Overview
Table 114. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. SciClone Pharmaceuticals Product
Table 116. SciClone Pharmaceuticals Recent Development
Table 117. Takeda Corporation Information
Table 118. Takeda Description and Business Overview
Table 119. Takeda Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Takeda Product
Table 121. Takeda Recent Development
Table 122. Roche Corporation Information
Table 123. Roche Description and Business Overview
Table 124. Roche Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Roche Product
Table 126. Roche Recent Development
Table 127. Sanofi Corporation Information
Table 128. Sanofi Description and Business Overview
Table 129. Sanofi Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Sanofi Product
Table 131. Sanofi Recent Development
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Polypeptide Drug Players
Table 136. Polypeptide Drug Customers List
Table 137. Polypeptide Drug Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Polypeptide Drug Product Picture
Figure 2. Global Polypeptide Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Nasal Administration Product Picture
Figure 5. Lung Administration Product Picture
Figure 6. Oral Administration Product Picture
Figure 7. Transdermal Administration Product Picture
Figure 8. Global Polypeptide Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Immunity Regulating Medicine (Allergy Infection and Immune)
Figure 10. Digestive System Drugs (Gastrointestinal Type)
Figure 11. Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure 12. Gynecologic or Obstetric Drug
Figure 13. Tumor Drug
Figure 14. Urinary System Drug
Figure 15. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure 16. Polypeptide Drug Report Years Considered
Figure 17. Global Polypeptide Drug Market Size 2015-2026 (US$ Million)
Figure 18. Global Polypeptide Drug Sales 2015-2026 (MT)
Figure 19. Global Polypeptide Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Polypeptide Drug Sales Market Share by Region (2015-2020)
Figure 21. Global Polypeptide Drug Sales Market Share by Region in 2019
Figure 22. Global Polypeptide Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global Polypeptide Drug Revenue Market Share by Region in 2019
Figure 24. Global Polypeptide Drug Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Polypeptide Drug Revenue in 2019
Figure 26. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Polypeptide Drug Sales Market Share by Type (2015-2020)
Figure 28. Global Polypeptide Drug Sales Market Share by Type in 2019
Figure 29. Global Polypeptide Drug Revenue Market Share by Type (2015-2020)
Figure 30. Global Polypeptide Drug Revenue Market Share by Type in 2019
Figure 31. Global Polypeptide Drug Market Share by Price Range (2015-2020)
Figure 32. Global Polypeptide Drug Sales Market Share by Application (2015-2020)
Figure 33. Global Polypeptide Drug Sales Market Share by Application in 2019
Figure 34. Global Polypeptide Drug Revenue Market Share by Application (2015-2020)
Figure 35. Global Polypeptide Drug Revenue Market Share by Application in 2019
Figure 36. Japan Polypeptide Drug Sales Growth Rate 2015-2026 (MT)
Figure 37. Japan Polypeptide Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. Japan Polypeptide Drug Market Share in Global Market 2015-2026
Figure 39. Japan 5 and 10 Largest Polypeptide Drug Players Market Share by Revenue in Polypeptide Drug in 2019
Figure 40. Japan Polypeptide Drug Revenue Share by Type (2015-2020)
Figure 41. Japan Polypeptide Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 42. Japan Polypeptide Drug Revenue Share by Application (2015-2020)
Figure 43. Japan Polypeptide Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 44. North America Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 45. North America Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. North America Polypeptide Drug Sales Market Share by Country in 2019
Figure 47. North America Polypeptide Drug Revenue Market Share by Country in 2019
Figure 48. U.S. Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 49. U.S. Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Canada Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 51. Canada Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 53. Europe Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 54. Europe Polypeptide Drug Sales Market Share by Country in 2019
Figure 55. Europe Polypeptide Drug Revenue Market Share by Country in 2019
Figure 56. Germany Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 57. Germany Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. France Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 59. France Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. U.K. Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 61. U.K. Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Italy Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 63. Italy Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Russia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 65. Russia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Asia Pacific Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 67. Asia Pacific Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific Polypeptide Drug Sales Market Share by Region in 2019
Figure 69. Asia Pacific Polypeptide Drug Revenue Market Share by Region in 2019
Figure 70. China Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 71. China Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 73. Japan Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. South Korea Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 75. South Korea Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. India Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 77. India Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Australia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 79. Australia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Taiwan Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 81. Taiwan Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Indonesia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 83. Indonesia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Thailand Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 85. Thailand Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Malaysia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 87. Malaysia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Philippines Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 89. Philippines Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Vietnam Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 91. Vietnam Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 93. Latin America Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Polypeptide Drug Sales Market Share by Country in 2019
Figure 95. Latin America Polypeptide Drug Revenue Market Share by Country in 2019
Figure 96. Mexico Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 97. Mexico Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 99. Brazil Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 101. Argentina Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Middle East and Africa Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 103. Middle East and Africa Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Polypeptide Drug Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Polypeptide Drug Revenue Market Share by Country in 2019
Figure 106. Turkey Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 107. Turkey Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 109. Saudi Arabia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 111. U.A.E Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Porter's Five Forces Analysis
Figure 113. Polypeptide Drug Value Chain
Figure 114. Channels of Distribution
Figure 115. Distributors Profiles
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
  • Investigation Report on Chinese Hydroxychloroquine (HCQ) Market, 2020-2024
    Published: 20-Oct-2020        Price: US 2600 Onwards        Pages: 50
    Description Hydroxychloroquine(HCQ) is an antimalarial drug. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine was listed in the United States in 1955, and the original research drug manufacturer was Sanofi. Hydroxychloroquine has been listed in Canada, France, Germany, Australia, China, Japan and other countries, and many companies worldwide have produced generic drugs of hydroxychloroquine. The indications for hydroxychloroquine include malari......
  • Global and Japan Human Immunoglobulin Market Insights, Forecast to 2026
    Published: 19-Oct-2020        Price: US 3900 Onwards        Pages: 144
    Human Immunoglobulin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Human Immunoglobulin market is ......
  • (COVID-19 Version) Global Primary Immunodeficiency Diseases Treatment Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Primary Immunodeficiency Diseases Treatment market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Primary Immunodeficiency Diseases Treatment industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company sh......
  • (COVID-19 Version) Global Primary Biliary Cirrhosis Drug Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 98
    Summary The report forecast global Primary Biliary Cirrhosis Drug market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Primary Biliary Cirrhosis Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Primar......
  • (COVID-19 Version) Global Prednisone Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 102
    Summary The report forecast global Prednisone market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Prednisone industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Prednisone by geography. The report splits the......
  • COVID-19 World Solid Organ Transplant Immunosuppressant Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 18-Oct-2020        Price: US 2800 Onwards        Pages: 92
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Solid Organ Transplant Immunosuppressant......
  • COVID-19 World Oral Vaccines Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 135
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oral Vaccines , covering Global total an......
  • COVID-19 World Methyl Salicylate Patches Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 102
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Methyl Salicylate Patches , covering Glo......
  • COVID-19 World Meningitis Vaccine Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 100
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Meningitis Vaccine , covering Global tot......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs